Vermont to require drug makers to explain price increases

Vermont is poised to become the first state requiring drug companies to explain their price increases, and Bob and Deborah Messing think that's a good idea. The Messings live in Montpelier and are in their early 70s. She's on Orencia, a Bristol-Myers Squibb product, for rheumatoid arthritis. He recently finished a course of Harvoni, made by Gilead Sciences Inc., to treat hepatitis C.
Read more: http://snapzu.com/geoleo/vermont-to-require-drug-makers-to-explain-price-increases